Transcranial magnetic stimulation for altering susceptibility of tissue to pharmaceuticals and radiation

• US 9,492,679 B2
• Filed: 07/15/2011
• Issued: 11/15/2016
• Est. Priority Date: 07/16/2010
• Status: Expired due to Fees

• Current Assignee: Brainsway, Ltd.
• Original Assignee: Rio Grande Neurosciences, Inc.
• Inventors: Schneider, M. Bret, Partsch, Michael J.
• Primary Examiner(s): Marmor, II, Charles A
• Assistant Examiner(s): Dorna, Carrie R
• Application Number:
  US13/808,806
• Publication Number:
  US 20130204330A1
• Time in Patent Office: 1,950 Days
• US Class Current: 1/1
• CPC Class Codes: A61N 1/06 for high-frequency therapy
• CPC Class Codes: A61N 1/406 using implantable thermoseeds or injected particles for localized hyperthermia preparations of seeds and particles A61K41/0052
• CPC Class Codes: A61N 2/002 in combination with another treatment
• CPC Class Codes: A61N 2/02 using magnetic fields produced by coils, including single turn loops or electromagnets A61N2/12 takes precedence

Abstract

Described herein are methods for modulating the susceptibility of one or more target or tissue regions, and particularly one or more brain regions, to a therapeutic agent such as a drug, immune agent, compound, radiation, etc. In particular, the methods and systems described herein may include magnetic stimulation (including transcranial magnetic stimulation) of target or non-target regions to modulate the susceptibility of the one or more target or tissue regions to a therapeutic agent.

Claims

1. A method of increasing the effect of a drug upon a targeted area of a patient'"'"'s tissue by transcranial magnetic stimulation (TMS), the method comprising:

delivering a drug that reaches a target tissue via blood vessels to the patient;

steering a TMS electromagnet to deliver a first magnetic field energy to the target tissue, wherein the first magnetic field energy has a low frequency of 5 Hz or less, wherein the TMS electromagnet is oriented so that an induced current in the target tissue or a principle current at an apex of the TMS electromagnet is oriented transversely to an anterior to posterior (AP) axis of the patient'"'"'s head; and

applying the first magnetic field energy to increase perfusion of the target tissue, so that availability of drug to the target tissue is increased.

2. The method of claim 1, further comprising applying a second magnetic field energy to a non-target tissue to decrease perfusion of the non-target tissue, so that availability of the drug to the non-target tissue is reduced.

3. The method of claim 1, wherein steering the TMS electromagnet further comprises steering a plurality of TMS coils to deliver the first magnetic field energy to the target tissue.

4. The method of claim 1, wherein applying the first magnetic energy further comprises applying the first magnetic energy at a low frequency between 0.5 Hz to 3 Hz.

5. The method of claim 1, wherein the target tissue is a deep brain tissue region.

6. The method of claim 1, wherein applying the first magnetic field energy is performed simultaneously with delivering the drug.

7. A method for increasing the effect of a drug upon a targeted area of a patient'"'"'s tissue by transcranial magnetic stimulation (TMS), the method comprising:

delivering a drug that reaches a target tissue via blood vessels to the patient;

steering a TMS electromagnet to deliver a first magnetic field energy to the target tissue;

applying the first magnetic field energy to the target tissue to increase perfusion of the target tissue, so that availability of the drug to the target tissues is increased; and

applying a second magnetic field energy to a non-target tissue to decrease perfusion of the non-target tissue, so that availability of the drug to the non-target tissue is reduced,

wherein the first magnetic field energy has a low frequency of 5 Hz or less, wherein the TMS electromagnet is oriented so that an induced current from the TMS electromagnet is oriented transversely to an anterior to posterior (AP) axis of the patient'"'"'s head.

8. The method of claim 7, wherein steering the TMS electromagnet further comprises steering a plurality of TMS coils to deliver the first magnetic field energy to the target tissue.

9. The method of claim 7, wherein the target tissue is a deep brain tissue region.

10. The method of claim 7, wherein applying the first magnetic field energy is performed simultaneously with delivering the drug.

11. A method of increasing the effect of a drug upon a targeted area of a patient'"'"'s head by transcranial magnetic stimulation (TMS), the method comprising:

delivering a drug that reaches a target tissue via blood vessels to the patient;

steering a plurality of TMS electromagnets to deliver a first magnetic field energy to the target tissue, wherein the first magnetic field energy has a low frequency of 5 Hz or less, wherein the TMS electromagnet is oriented so that an induced current in the target tissue or a principle current at an apex of at least one of the TMS electromagnets is oriented transversely to an anterior to posterior (AP) axis of the patient'"'"'s head; and

applying the first magnetic field energy to increase perfusion of the target tissue, so that availability of drug to the target tissue is increased.

12. A method of increasing the effect of a drug upon a targeted area of a patient'"'"'s tissue by transcranial magnetic stimulation (TMS), the method comprising:

delivering a drug that reaches a target tissue via blood vessels to the patient;

steering a TMS electromagnet to deliver a first magnetic field energy to the target tissue, wherein the first magnetic field energy has a low frequency of 5 Hz or less, wherein the TMS electromagnet is oriented so that a current induced from the TMS electromagnet is oriented transversely to an anterior to posterior (AP) axis of the patient'"'"'s head; and

applying the first magnetic field energy to increase perfusion of the target tissue, so that availability of drug to the target tissue is increased.

13. The method of claim 12, further comprising applying a second magnetic field energy to a non-target tissue to decrease perfusion of the non-target tissue, so that availability of the drug to the non-target tissue is reduced.

14. The method of claim 12, wherein steering the TMS electromagnet further comprises steering a plurality of TMS coils to deliver the first magnetic field energy to the target tissue.

15. The method of claim 12, wherein applying the first magnetic energy further comprises applying the first magnetic energy at a low frequency between 0.5 Hz to 3 Hz.

16. The method of claim 12, wherein the target tissue is a deep brain tissue region.

17. The method of claim 12, wherein applying the first magnetic field energy is performed simultaneously with delivering the drug.